title: MIIP accelerates epidermal growth factor receptor protein turnover and attenuates proliferation in non-small cell lung cancer.
abstract: The migration and invasion inhibitory protein (MIIP) has been discovered recently to have inhibitory functions in cell proliferation and migration. Overexpression of MIIP reduced the intracellular steady-state level of epidermal growth factor receptor (EGFR) protein in lung cancer cells with no effect on EGFR mRNA expression compared to that in the control cells. This MIIP-promoted EGFR protein degradation was reversed by proteasome and lysosome inhibitors, suggesting the involvement of both proteasomal and lysosomal pathways in this degradation. This finding was further validated by pulse-chase experiments using 35S-methionine metabolic labeling. We found that MIIP accelerates EGFR protein turnover via proteasomal degradation in the endoplasmic reticulum and then via the lysosomal pathway after its entry into endocytic trafficking. MIIP-stimulated downregulation of EGFR inhibits downstream activation of Ras and blocks the MEK signal transduction pathway, resulting in inhibition of cell proliferation. The negative correlation between MIIP and EGFR protein expression was validated in lung adenocarcinoma samples. Furthermore, the higher MIIP protein expression predicts a better overall survival of Stage IA-IIIA lung adenocarcinoma patients who underwent radical surgery. These findings reveal a new mechanism by which MIIP inhibits cell proliferation.
authors.affiliation: Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.|State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China.
authors.forename: Jing
authors.initials: J
authors.lastname: Wen
authors.affiliation: State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China.|Department of Thoracic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China.
authors.forename: Jianhua
authors.initials: J
authors.lastname: Fu
authors.affiliation: State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China.|Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China.
authors.forename: Yihong
authors.initials: Y
authors.lastname: Ling
authors.affiliation: Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
authors.forename: Wei
authors.initials: W
authors.lastname: Zhang
mesh_terms: D000230:Adenocarcinoma / Q000401:mortality / Q000473:pathology*; D000077192:Adenocarcinoma of Lung; D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000473:pathology*; D002352:Carrier Proteins / Q000378:metabolism*; D045744:Cell Line, Tumor; D002465:Cell Movement; D049109:Cell Proliferation; D066246:ErbB Receptors / Q000235:genetics / Q000378:metabolism*; D005260:Female; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D012333:RNA, Messenger / Q000235:genetics; D015398:Signal Transduction
chemical_list: D002352:Carrier Proteins; D047908:Intracellular Signaling Peptides and Proteins; C480900:MIIP protein, human; D012333:RNA, Messenger; C512478:EGFR protein, human; D066246:ErbB Receptors
keywords: epidermal growth factor receptor; migration and invasion inhibitory protein; non-small cell lung cancer; protein degradation
references.citation: Ann Surg Oncol. 2013 May;20(5):1668-75
references.pmid: 23429937
references.citation: J Biol Chem. 1986 Nov 15;261(32):15233-41
references.pmid: 3490480
references.citation: Oncogene. 2009 Aug;28 Suppl 1:S32-7
references.pmid: 19680294
references.citation: Annu Rev Cell Dev Biol. 2003;19:649-76
references.pmid: 14570585
references.citation: J Cell Biol. 1992 Mar;116(5):1071-80
references.pmid: 1740466
references.citation: Oncotarget. 2016 Jan 26;7(4):3884-96
references.pmid: 26646697
references.citation: Proc Natl Acad Sci U S A. 1978 Jul;75(7):3327-31
references.pmid: 28524
references.citation: Science. 1995 May 5;268(5211):726-31
references.pmid: 7732382
references.citation: Exp Cell Res. 1989 Jul;183(1):197-206
references.pmid: 2786814
references.citation: Genes Chromosomes Cancer. 2000 Jul;28(3):342-6
references.pmid: 10862041
references.citation: Oncol Rep. 2015 Jun;33(6):2771-8
references.pmid: 25873164
references.citation: J Membr Biol. 1986;90(2):97-105
references.pmid: 3014153
references.citation: Cancer Res. 2010 Feb 1;70(3):1024-32
references.pmid: 20103646
references.citation: Mol Cell Biol. 1984 Apr;4(4):571-5
references.pmid: 6325885
references.citation: J Am Soc Nephrol. 1994 Dec;5(6):1288-99
references.pmid: 7893993
references.citation: J Biol Chem. 2010 Feb 5;285(6):3554-60
references.pmid: 20008322
references.citation: Biochem Biophys Res Commun. 1988 May 31;153(1):96-103
references.pmid: 2454110
references.citation: J Biol Chem. 1993 Sep 15;268(26):19312-20
references.pmid: 8396132
references.citation: Oncotarget. 2014 Apr 15;5(7):1969-86
references.pmid: 24722501
references.citation: Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):13970-5
references.pmid: 14617774
references.citation: Endocrinology. 1985 Feb;116(2):528-35
references.pmid: 2981666
references.citation: Exp Cell Res. 2009 Feb 15;315(4):683-96
references.pmid: 19278030
references.citation: CA Cancer J Clin. 2015 Mar;65(2):87-108
references.pmid: 25651787
references.citation: PLoS One. 2015 Oct 14;10(10):e0140404
references.pmid: 26466362
references.citation: J Cell Physiol. 1998 Nov;177(2):282-8
references.pmid: 9766525
references.citation: Cancer Res. 2008 May 15;68(10):3803-9
references.pmid: 18483264
references.citation: Chin J Cancer. 2011 Jan;30(1):5-12
references.pmid: 21192840
references.citation: EMBO J. 2002 Dec 16;21(24):6820-31
references.pmid: 12486003
references.citation: J Biol Chem. 1991 Jun 15;266(17):11083-94
references.pmid: 1645724
references.citation: FASEB J. 2000 Nov;14(14):2147-57
references.pmid: 11053235
references.citation: J Biol Chem. 2010 Apr 9;285(15):11219-26
references.pmid: 20133936
references.citation: Mod Pathol. 2011 Jul;24(7):932-43
references.pmid: 21423157
references.citation: Oncogene. 2010 Jun 17;29(24):3501-8
references.pmid: 20418911
references.citation: Adv Drug Deliv Rev. 2003 Nov 14;55(11):1385-403
references.pmid: 14597137
references.citation: Biophys J. 2003 Aug;85(2):730-43
references.pmid: 12885624
references.citation: Chin J Cancer. 2015 Sep 14;34(11):502-7
references.pmid: 26370301
references.citation: Exp Cell Res. 2003 Mar 10;284(1):78-88
references.pmid: 12648467
references.citation: Nat Rev Mol Cell Biol. 2003 Dec;4(12):938-47
references.pmid: 14685172
references.citation: Chin J Cancer. 2015 Jul 18;34(7):310-9
references.pmid: 26187152